Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.

Peshkin BN, Ladd MK, Isaacs C, Segal H, Jacobs A, Taylor KL, Graves KD, O'Neill SC, Schwartz MD.

J Cancer Educ. 2019 Aug 11. doi: 10.1007/s13187-019-01599-y. [Epub ahead of print]

PMID:
31402434
2.

Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer.

Hurtado-de-Mendoza A, Graves KD, Gómez-Trillos S, Song M, Anderson L, Campos C, Carrera P, Ostrove N, Peshkin BN, Schwartz MD, Ficca N, Cupertino AP, Gonzalez N, Otero A, Huerta E, Sheppard VB.

J Community Genet. 2019 May 18. doi: 10.1007/s12687-019-00423-w. [Epub ahead of print]

PMID:
31104207
3.

Factors associated with Chinese American and White cancer survivors' physical and psychological functioning.

Wang JH, Gomez SL, Brown RL, Davis K, Allen L, Huang E, Chentsova Dutton Y, Schwartz MD.

Health Psychol. 2019 May;38(5):455-465. doi: 10.1037/hea0000666.

PMID:
31045429
4.

RE: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.

Peshkin BN, Isaacs C, Schwartz MD.

J Natl Cancer Inst. 2019 Mar 5. pii: djz028. doi: 10.1093/jnci/djz028. [Epub ahead of print] No abstract available.

PMID:
30838400
5.

Ilnacorahenryi, a new species of plant bug from Mexico (Heteroptera, Miridae, Orthotylinae, Orthotylini).

Schwartz MD.

Zookeys. 2018 Nov 15;(796):241-252. doi: 10.3897/zookeys.796.21285. eCollection 2018.

6.

A description of a new genus and new species of sotol-feeding Eccritotarsini (Hemiptera: Heteroptera: Miridae: Bryocorinae) from Durango, Mexico.

Menard KL, Schwartz MD.

Zootaxa. 2018 Nov 7;4514(2):283-292. doi: 10.11646/zootaxa.4514.2.11.

PMID:
30486221
7.

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Ladd MK, Peshkin BN, Senter L, Baldinger S, Isaacs C, Segal H, Philip S, Phillips C, Shane K, Martin A, Weinstein V, Pilarski R, Jeter J, Sweet K, Hatten B, Wurtmann EJ, Phippen S, Bro D, Schwartz MD.

Transl Behav Med. 2018 Nov 10. doi: 10.1093/tbm/iby101. [Epub ahead of print]

PMID:
30418620
8.

Contingency Medical Countermeasures for Mass Nerve-Agent Exposure: Use of Pharmaceutical Alternatives to Community Stockpiled Antidotes.

Schwartz MD, Sutter ME, Eisnor D, Kirk MA.

Disaster Med Public Health Prep. 2018 Oct 15:1-8. doi: 10.1017/dmp.2018.99. [Epub ahead of print]

PMID:
30319091
9.

Electronic Health Record-Based Screening for Substance Abuse.

Alemi F, Avramovic S, Schwartz MD.

Big Data. 2018 Sep 1;6(3):214-224. doi: 10.1089/big.2018.0002. Epub 2018 Sep 19.

10.

HbA1c, lipid profiles and risk of incident type 2 Diabetes in United States Veterans.

Davis PJ, Liu M, Sherman S, Natarajan S, Alemi F, Jensen A, Avramovic S, Schwartz MD, Hayes RB.

PLoS One. 2018 Sep 13;13(9):e0203484. doi: 10.1371/journal.pone.0203484. eCollection 2018.

11.

Prior antibiotic exposure and risk of type 2 diabetes among Veterans.

Davis PJ, Liu M, Alemi F, Jensen A, Avramovic S, Levy E, Hayes RB, Schwartz MD.

Prim Care Diabetes. 2019 Feb;13(1):49-56. doi: 10.1016/j.pcd.2018.07.001. Epub 2018 Jul 17.

PMID:
30025678
12.

Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.

Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR.

Expert Opin Ther Targets. 2018 Jun;22(6):513-526. doi: 10.1080/14728222.2018.1480723. Epub 2018 Jun 5. Review.

PMID:
29798691
13.

Health state utilities among contemporary prostate cancer patients on active surveillance.

Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E.

Transl Androl Urol. 2018 Apr;7(2):197-202. doi: 10.21037/tau.2017.03.80.

14.

Protocol for the CHORD project (community health outreach to reduce diabetes): a cluster-randomized community health worker trial to prevent diabetes.

Islam N, Gepts T, Lief I, Gore R, Levy N, Tanner M, Fang Y, Sherman SE, Schwartz MD.

BMC Public Health. 2018 Apr 19;18(1):521. doi: 10.1186/s12889-018-5419-4.

15.

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.

Schwartz MD, Peshkin BN, Isaacs C, Willey S, Valdimarsdottir HB, Nusbaum R, Hooker G, O'Neill S, Jandorf L, Kelly SP, Heinzmann J, Zidell A, Khoury K.

Breast Cancer Res Treat. 2018 Aug;170(3):517-524. doi: 10.1007/s10549-018-4773-3. Epub 2018 Apr 2.

16.

Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine.

Schwartz MD, Palmerston JB, Lee DL, Hoener MC, Kilduff TS.

Front Pharmacol. 2018 Feb 2;9:35. doi: 10.3389/fphar.2018.00035. eCollection 2018.

17.

Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.

Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicuña B, Schwartz MD, Kinney AY.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1772-1780. doi: 10.1158/1055-9965.EPI-17-0389. Epub 2017 Sep 29.

18.

Sleep/Wake Physiology and Quantitative Electroencephalogram Analysis of the Neuroligin-3 Knockout Rat Model of Autism Spectrum Disorder.

Thomas AM, Schwartz MD, Saxe MD, Kilduff TS.

Sleep. 2017 Oct 1;40(10). doi: 10.1093/sleep/zsx138.

PMID:
28958035
19.

Informational needs during active surveillance for prostate cancer: A qualitative study.

Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Ciprut S, Sedlander E.

Patient Educ Couns. 2018 Feb;101(2):241-247. doi: 10.1016/j.pec.2017.08.022. Epub 2017 Sep 1.

20.

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.

Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, DeMarco T, Hooker G, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Heinzmann J, Kinney AY, Schwartz MD.

JNCI Cancer Spectr. 2017 Sep;1(1):pkx002. doi: 10.1093/jncics/pkx002. Epub 2017 Sep 22.

21.

Detection of ingested nitromethane and reliable creatinine assessment using multiple common analytical methods.

Murphy CM, Devlin JJ, Beuhler MC, Cheifetz P, Maynard S, Schwartz MD, Kacinko S.

Clin Toxicol (Phila). 2018 Apr;56(4):237-244. doi: 10.1080/15563650.2017.1360497. Epub 2017 Aug 17.

PMID:
28814126
22.
23.

Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.

Tsai HT, Isaacs C, Lynce FC, O'Neill SC, Liu C, Schwartz MD, Selvam N, Zhou Y, Potosky AL.

J Natl Compr Canc Netw. 2017 May;15(5):601-607.

24.

Identification of BRCA1 and BRCA2 Mutation Carriers Through a Traceback Framework: Consent, Privacy, and Autonomy.

Schwartz MD.

J Clin Oncol. 2017 Jul 10;35(20):2226-2228. doi: 10.1200/JCO.2017.72.8774. Epub 2017 May 2. No abstract available.

PMID:
28463631
25.

Cntnap2 Knockout Rats and Mice Exhibit Epileptiform Activity and Abnormal Sleep-Wake Physiology.

Thomas AM, Schwartz MD, Saxe MD, Kilduff TS.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw026.

PMID:
28364455
26.

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65.

O'Neill SC, Isaacs C, Lynce F, Graham DM, Chao C, Sheppard VB, Zhou Y, Liu C, Selvam N, Schwartz MD, Potosky AL.

Breast Cancer Res. 2017 Mar 31;19(1):45. doi: 10.1186/s13058-017-0837-2.

27.

A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Knerr S, Wernli KJ, Leppig K, Ehrlich K, Graham AL, Farrell D, Evans C, Luta G, Schwartz MD, O'Neill SC.

Contemp Clin Trials. 2017 May;56:25-33. doi: 10.1016/j.cct.2017.02.009. Epub 2017 Feb 28.

28.

Measuring Practicing Clinicians' Information Literacy. An Exploratory Analysis in the Context of Panel Management.

Dixon BE, Barboza K, Jensen AE, Bennett KJ, Sherman SE, Schwartz MD.

Appl Clin Inform. 2017 Feb 15;8(1):149-161. doi: 10.4338/ACI-2016-06-RA-0083.

29.

Reply to P.R. Benusiglio et al.

Kinney AY, Kohlmann W, Brumbach BH, Schwartz MD.

J Clin Oncol. 2017 Apr 10;35(11):1255-1256. doi: 10.1200/JCO.2016.70.9303. Epub 2017 Jan 23. No abstract available.

PMID:
28113008
30.

Direct Approach to Quantum Tunneling.

Andreassen A, Farhi D, Frost W, Schwartz MD.

Phys Rev Lett. 2016 Dec 2;117(23):231601. Epub 2016 Nov 30.

PMID:
27982632
31.

Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.

Black SW, Schwartz MD, Chen TM, Hoener MC, Kilduff TS.

Biol Psychiatry. 2017 Nov 1;82(9):623-633. doi: 10.1016/j.biopsych.2016.10.012. Epub 2016 Oct 18.

32.

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition.

Schwartz MD, Black SW, Fisher SP, Palmerston JB, Morairty SR, Hoener MC, Kilduff TS.

Neuropsychopharmacology. 2017 May;42(6):1305-1314. doi: 10.1038/npp.2016.216. Epub 2016 Sep 23.

34.

Qualitative study on decision-making by prostate cancer physicians during active surveillance.

Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E.

BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2.

35.

Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD.

J Clin Oncol. 2016 Aug 20;34(24):2914-24. doi: 10.1200/JCO.2015.65.9557. Epub 2016 Jun 20.

36.

Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy.

Evans CN, Brewer NT, Vadaparampil ST, Boisvert M, Ottaviano Y, Lee MC, Isaacs C, Schwartz MD, O'Neill SC.

Breast Cancer Res Treat. 2016 Apr;156(3):549-555. doi: 10.1007/s10549-016-3780-5. Epub 2016 Apr 8.

37.

Health Systems Science Curricula in Undergraduate Medical Education: Identifying and Defining a Potential Curricular Framework.

Gonzalo JD, Dekhtyar M, Starr SR, Borkan J, Brunett P, Fancher T, Green J, Grethlein SJ, Lai C, Lawson L, Monrad S, O'Sullivan P, Schwartz MD, Skochelak S.

Acad Med. 2017 Jan;92(1):123-131. doi: 10.1097/ACM.0000000000001177.

PMID:
27049541
38.

Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.

Schwartz MD, Nguyen AT, Warrier DR, Palmerston JB, Thomas AM, Morairty SR, Neylan TC, Kilduff TS.

eNeuro. 2016 Mar 21;3(2). pii: ENEURO.0018-16.2016. doi: 10.1523/ENEURO.0018-16.2016. eCollection 2016 Mar-Apr.

39.

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.

Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, Hooker GW, DeMarco TA, Heinzmann JE, McKinnon W, McCormick SR, Davis C, Forman AD, Lebensohn AP, Dalton E, Tully DM, Graves KD, Similuk M, Kelly S, Peshkin BN.

Fam Cancer. 2016 Oct;15(4):529-39. doi: 10.1007/s10689-016-9900-x.

40.

Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.

Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS, Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS.

J Oncol Pract. 2016 Jan;12(1):59, e1-13. doi: 10.1200/JOP.2015.004838.

41.

The Neurobiology of Sleep and Wakefulness.

Schwartz MD, Kilduff TS.

Psychiatr Clin North Am. 2015 Dec;38(4):615-44. doi: 10.1016/j.psc.2015.07.002. Epub 2015 Aug 28. Review.

42.

Chaos in the Clinic: Characteristics and Consequences of Practices Perceived as Chaotic.

Perez HR, Beyrouty M, Bennett K, Baier Manwell L, Brown RL, Linzer M, Schwartz MD.

J Healthc Qual. 2017 Jan/Feb;39(1):43-53. doi: 10.1097/JHQ.0000000000000016.

PMID:
26566238
43.

Adoption of Gene Expression Profiling for Breast Cancer in US Oncology Practice for Women Younger Than 65 Years.

O'Neill SC, Isaacs C, Chao C, Tsai HT, Liu C, Ekezue BF, Selvam N, Kessler LG, Schwartz MD, Lobo T, Potosky AL.

J Natl Compr Canc Netw. 2015 Oct;13(10):1216-24.

44.

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.

Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, Valdimarsdottir HB, Forman AD, Joines JR, Davis C, McCormick SR, McKinnon W, Graves KD, Isaacs C, Garber J, Wood M, Jandorf L, Schwartz MD.

J Genet Couns. 2016 Jun;25(3):472-82. doi: 10.1007/s10897-015-9897-6. Epub 2015 Oct 12.

45.

Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.

Fisher SP, Schwartz MD, Wurts-Black S, Thomas AM, Chen TM, Miller MA, Palmerston JB, Kilduff TS, Morairty SR.

Sleep. 2016 Feb 1;39(2):379-91. doi: 10.5665/sleep.5448.

46.

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.

Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Virgo KS, Lynch K, Andrews JE, Aguado Loi CX, Bauer JE, Casares C, Bourquardez Clark E, Kondoff MR, Molina AD, Abdollahian M, Walker G, Sutphen R.

JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048. Erratum in: JAMA Oncol. 2016 Mar;2(3):404.

PMID:
26426480
47.

Predictors and Outcomes of Burnout in Primary Care Physicians.

Rabatin J, Williams E, Baier Manwell L, Schwartz MD, Brown RL, Linzer M.

J Prim Care Community Health. 2016 Jan;7(1):41-3. doi: 10.1177/2150131915607799. Epub 2015 Sep 28.

48.

Acceptability and pilot efficacy trial of a web-based breast reconstruction decision support aid for women considering mastectomy.

Manne SL, Topham N, D'Agostino TA, Myers Virtue S, Kirstein L, Brill K, Manning C, Grana G, Schwartz MD, Ohman-Strickland P.

Psychooncology. 2016 Dec;25(12):1424-1433. doi: 10.1002/pon.3984. Epub 2015 Sep 18.

PMID:
26383833
49.

Lilac and honeysuckle phenology data 1956-2014.

Rosemartin AH, Denny EG, Weltzin JF, Lee Marsh R, Wilson BE, Mehdipoor H, Zurita-Milla R, Schwartz MD.

Sci Data. 2015 Jul 21;2:150038. doi: 10.1038/sdata.2015.38. eCollection 2015.

50.

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years.

Potosky AL, O'Neill SC, Isaacs C, Tsai HT, Chao C, Liu C, Ekezue BF, Selvam N, Kessler LG, Zhou Y, Schwartz MD.

Cancer. 2015 Nov 15;121(22):4062-70. doi: 10.1002/cncr.29621. Epub 2015 Aug 20.

Supplemental Content

Loading ...
Support Center